Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-31

Clinical Trial Update: Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM) [NA]

View source ↗

Summary

REDEEM is a recruiting clinical trial testing a risk-guided disease management plan to prevent heart failure in patients who have previously received chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Baker Heart and Diabetes Institute | Conditions: Heart Failure | NA | Status: RECRUITING